What treatment is going to be offered for this patient?
On this image, this patient presents with intraretinal fluid and hyperreflectivity in the deep retina. This patient was diagnosed with wet AMD and offered treatment with an anti-VEGF compound.
In general, there is a tremendous burden on patients, their family members and medical practices to treat wet AMD.
In today’s journal club we review the LADDER study, a phase 2 randomized clinical trial published in the journal Ophthalmology. This study evaluated a new reservoir system called a Port Delivery System for the slow release of ranibizumab.
In this journal club's accompanying 12 min. video, Dr. Sharma will review:
- Learn how the Port Delivery System works
- The efficacy of this delivery system
- The risk profile of the device